The present invention generally provides stilbenoid derivatives and methods for using stilbenoid derivatives to modulate the activity of cannabinoid receptors or scavenge reactive nitrogen species.
Cb2 Receptor Modulators In Neurodegenerative Diseases And Applications Of The Same
Compositions for the treatment of neurodegenerative diseases are disclosed. Methods of treating and monitoring progression of a neurodegenerative disease are disclosed. According to the present invention, a selective CB2 receptor modulator may be administered to a mammal for the treatment of a neurodegenerative disease.
- STATE UNIVERSITY AR, US Paul L. Prather - Little Rock AR, US Luis Fabricio Medina-Bolivar - Memphis TN, US Philip R. Mayeux - Little Rock AR, US
International Classification:
A61K 31/7034
Abstract:
The present invention generally provides stilbenoid derivatives and methods for using stilbenoid derivatives to modulate the activity of cannabinoid receptors or scavenge reactive nitrogen species.
Chemists have been studying and developing synthetic cannabinoids as part of scientific research into how it could be used for medical purposes, said Paul Prather, a professor at the University of Arkansas for Medical Sciences. Prather, who has been studying the therapeutic use of synthetic cannabin